Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Martek, General Mills seek shelf-stable DHA

This article was originally published in The Tan Sheet

Executive Summary

The nutritional oils firm looks to expand the use of DHA in long shelf-life foods through a partnership with General Mills. "We do not have all product categories licked yet," such as dry cereal, said Martek Biosciences Chief Financial Officer Pete Buzy Sept. 21 at the UBS Global Life Science Conference in New York. The agreement signed in February gives Martek rights to use General Mills' technology in exchange for exclusive use by GM of Martek's DHA formula in some applications. The deal is separate from a 15-year DHA license and supply agreement the firms signed in 2006 (1"The Tan Sheet" June 19, 2006, In Brief). A spokeswoman said Martek expects to commercialize its DHA in long shelf-life foods by early 2011. The Columbia, Md.-based maker of life'sDHA projects the market for omega-3 fortified products will reach $8 billion by 2012
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS103367

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel